Improvisational music therapy for children with autism spectrum disorder assessed using brain imaging

Music therapy outcome study for children with Autism Spectrum Disorder through integration of child neuroimaging and neuropsychology: An exploratory study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN18340173

Enrollment

Registered

2019-04-04

Start date

2018-09-15

Completion date

Unknown

Last updated

2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder Mental and Behavioural Disorders

Interventions

Music Therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged between 24 - 72 months 2. Autism Spectrum Disorder confirmed by DSM-V and ADOS

Exclusion criteria

Exclusion criteria: 1. Hearing/visual impairement, congenital genetic disease (cerebral palsy) 2. Seizure and other neurological condition 3. Other psychiatric disorder such as ADHD, schizophrenia, depression, bi-polar 4. Previous and on-going experiences of music therapy 5. Medication such as risperidone, aripirazole, SSRI, etc.

Design outcomes

Primary

Measure	Time frame
Severity of autism measured using the Autism Diagnostic Observation Schedule (ADOS) and Childhood Autism Rating Scale-2 (CARS 2) at baseline, 6 months, post-intervention (12 months)	—

Secondary

Measure	Time frame
Collected at baseline, in-between (6 month later/ approx. 24th session), and post (12 month later, 48th session): Child questionnaires: 1. Social Responsiveness Scale (SRS) 2. Aberrant Behavior Checklist (ABC) 3. The Social Communication Questionnaire (SCQ) 4. Social Maturity Scale (SMS) 5. Child Behavior Checklist 1.5-5 (CBCL 1.5-5) Parent’s questionnaires: 6. Beck Depression Inventory (BDI) 7. State-Trait Anxiety Inventory (STAI-T/S) 8. Maternal Behavior Research Instrument (MBRI) 9. Korean Parenting Stress Index (PSI) 10. Mental Health Continuum-Short Form (MHC-SF) 11. Carer-QoL-7D / Child QoL (VAS) 12. Concomitant Treatment form Pre and Post tests (baseline and 12 months later): 13. Neuroimaging: aMRI/DTI/rsfMRI 14. Psychoeducational Profile-Revised (PEP-R) 15. Baseline test only: Blood and Urine for detecting DNA and harmful environmental exposure 16. Post-trial in-depth interview with the mothers and the therapist (thematic analysis; qualitative study) 17. Behavioral analysis through video recording of music therapy session for establishing treatment fidelity 18. Parents/ therapists interviews after the completion of the trial	—

Measure

Time frame

Collected at baseline, in-between (6 month later/ approx. 24th session), and post (12 month later, 48th session): Child questionnaires: 1. Social Responsiveness Scale (SRS) 2. Aberrant Behavior Checklist (ABC) 3. The Social Communication Questionnaire (SCQ) 4. Social Maturity Scale (SMS) 5. Child Behavior Checklist 1.5-5 (CBCL 1.5-5) Parent’s questionnaires: 6. Beck Depression Inventory (BDI) 7. State-Trait Anxiety Inventory (STAI-T/S) 8. Maternal Behavior Research Instrument (MBRI) 9. Korean Parenting Stress Index (PSI) 10. Mental Health Continuum-Short Form (MHC-SF) 11. Carer-QoL-7D / Child QoL (VAS) 12. Concomitant Treatment form Pre and Post tests (baseline and 12 months later): 13. Neuroimaging: aMRI/DTI/rsfMRI 14. Psychoeducational Profile-Revised (PEP-R) 15. Baseline test only: Blood and Urine for detecting DNA and harmful environmental exposure 16. Post-trial in-depth interview with the mothers and the therapist (thematic analysis; qualitative study) 17. Behavioral analysis through video recording of music therapy session for establishing treatment fidelity 18. Parents/ therapists interviews after the completion of the trial

—

Countries

Korea, South

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026